Optimal Drug Treatment of Systolic Hypertension in the Elderly

ISSN： 1170-229X

Source： Drugs & Aging, Vol.25, Iss.1, 2008-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparative Evaluation of Amlodipine and Hydrochlorothiazide as Monotherapy in the Treatment of Isolated Systolic Hypertension in the Elderly

By Herrera J.

Clinical Drug Investigation, Vol. 19, Iss. 5, 2000-05 ,pp. : 317-326

Adis International

Access to resources Recommend Favorite

Improved Outcomes with Antihypertensive Medication in the Elderly with Isolated Systolic Hypertension

By Wang J-G. Staessen J.A.

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite

Ticlopidine: Isolated systolic hypertension in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1407, 2012-01 ,pp. : 37-38

Adis International

Access to resources Recommend Favorite

Eprosartan reduces systolic BP (SBP) and pulse pressure (PP) in elderly patients with isolated systolic hypertension (ISH)

Inpharma, Vol. 1, Iss. 1472, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Screening for cardiovascular and renal risk factors with subsequent intervention letter is effective in terms of increasing drug treatment for hypertension and/or hyperlipidaemia, but is "definitely not optimal"

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 452, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite